Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Inovio Pharmaceuticals Inc

INO
Current price
1.74 USD +0.02 USD (+1.16%)
Last closed 1.58 USD
ISIN US45773H4092
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 63 811 892 USD
Yield for 12 month -82.63 %
1Y
3Y
5Y
10Y
15Y
INO
21.11.2021 - 28.11.2021

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the University of Pennsylvania, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania. Address: 660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.83 USD

P/E ratio

Dividend Yield

Current Year

+217 756 USD

Last Year

+832 010 USD

Current Quarter

+116 994 USD

Last Quarter

Current Year

+217 756 USD

Last Year

-2 671 528 USD

Current Quarter

+116 994 USD

Last Quarter

Key Figures INO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -110 646 776 USD
Operating Margin TTM -17 410.77 %
Price to Earnings
Return On Assets TTM -49.45 %
PEG Ratio
Return On Equity TTM -115.42 %
Wall Street Target Price 7.83 USD
Revenue TTM 217 756 USD
Book Value 1.90 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 14.00 %
Dividend Yield
Gross Profit TTM -75 402 584 USD
Earnings per share -3.95 USD
Diluted Eps TTM -3.95 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics INO

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History INO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years 0
Consistent Years 0
Continuous Dividends 0
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:12
Payout Ratio
Last Split Date 25.01.2024

Stock Valuation INO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 128.41
Price Sales TTM 293.04
Enterprise Value EBITDA -1.09
Price Book MRQ 0.92

Financials INO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators INO

For 52 weeks

1.42 USD 13.44 USD
50 Day MA 1.89 USD
Shares Short Prior Month 5 354 671
200 Day MA 4.75 USD
Short Ratio 9.03
Shares Short 6 397 683
Short Percent 17.56 %